Study on the Safe Dosage and Therapeutic Effect of the Drug YY2201 Tablets on Patients With Advanced Cancer
Clinical trial NCT06976931 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06976931
- Sponsor
- Jiangsu YaYao Biotechnology Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-26
- Primary completion
- 2027-04-05
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.